Patents by Inventor Trunetta Ross

Trunetta Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapy-enhancing glucan
    Publication number: 20060009419
    Abstract: The present invention relates to methods of using neutral soluble glucan and monoclonal antibodies for antitumor therapy. Neutral soluble Beta (1,3; 1,6) glucan (NSG) enhances the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. The glucan does not stimulate the induction of inflammatory cytokines. Also described are methods of using whole glucan particles (WGP) as an immunomodulator by inducing a shift from a Th2 response to the Th1 response, leading to an enhanced antitumor cytotoxic T-cell response.
    Type: Application
    Filed: September 4, 2003
    Publication date: January 12, 2006
    Inventors: Gordon Ross, Trunetta Ross
  • Methods of using beta glucan as a radioprotective agent
    Publication number: 20050245480
    Abstract: The invention relates to methods for treating and preventing radiation and/or chemotherapy related injury and/or afflictions, such as myelosuppression and decreased macrophage activity, by administering a prophylactically or therapeutically effective amount of particulate, bioavailable ?(1,3; 1,6) glucan. The invention also relates to methods in which ?(1,3; 1,6) glucan is provided in the form of whole glucan particles, microparticulate ?-glucan particles or a combination thereof.
    Type: Application
    Filed: February 11, 2005
    Publication date: November 3, 2005
    Applicants: Biopolymer Engineering, Inc., University of Louisville Research Foundation
    Inventors: Gary Ostroff, Gordon Ross, Trunetta Ross